Item 2 – Unregistered Sales of Equity Securities and Use of Proceeds
−Removed: During the quarter ended March 31, 2022, Omega did not issue any shares of Omega common stock in exchange for Omega OP Units.
+Added: During the quarter ended June 30, 2022, Omega did not issue any shares of Omega common stock in exchange for Omega OP Units.
Issuer Purchases of Equity Securities
−Removed: On January 27, 2022, the Company authorized the repurchase of up to $500 million of our outstanding common stock from time to time through March 2025.
+Added: On January 27, 2022, the Board authorized the Company to repurchase of up to $500 million of our outstanding common stock from time to time through March 2025.
The Company is authorized to repurchase shares of its common stock in open market and privately negotiated transactions or in any other manner as determined by the Company’s management and in accordance with applicable law.
1 unchanged sentence
The Company has no obligation to repurchase any amount of its common stock, and such repurchases, if any, may be discontinued at any time.
−Removed: During the first quarter of 2022, we repurchased shares of our outstanding common stock as follows:
+Added: During the second quarter of 2022, we repurchased shares of our outstanding common stock as follows:
Total Number of
6 unchanged sentences
Paid per Share
−Removed: January 1, 2022 to January 31, 2022
−Removed: February 1, 2022 to February 28, 2022
−Removed: March 1, 2022 to March 31, 2022
+Added: April 1, 2022 to April 30, 2022
+Added: May 1, 2022 to May 31, 2022
+Added: June 1, 2022 to June 30, 2022
Item 6–Exhibits
3 unchanged sentences
Section 1350 Certification of the Chief Financial Officer of Omega Healthcare Investors, Inc.*
−Removed: The following financial statements from the Company’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2022, formatted in Inline XBRL:
+Added: The following financial statements from the Company’s Quarterly Report on Form 10-Q for the quarter ended June 30, 2022, formatted in Inline XBRL:
(i) Consolidated Balance Sheets, (ii) Consolidated Statements of Operations, (iii) Consolidated Statements of Comprehensive Income, (iv) Consolidated Statements of Changes in Equity, (v) Consolidated Statements of Cash Flows, and (vi) Notes to Consolidated Financial Statements, tagged as blocks of text and including detailed tags.
3 unchanged sentences
OMEGA HEALTHCARE INVESTORS, INC.
+Added: August 2, 2022
TAYLOR PICKETT
1 unchanged sentence
Chief Executive Officer
+Added: August 2, 2022
/S/ ROBERT O.
1 unchanged sentence
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.